Lv7
3540 积分 2020-12-23 加入
Abstract 4013: Combination of BTK inhibitor orelabrutinib, anti-CD19 antibody tafasitamab, and IMiD lenalidomide for the treatment of B cell malignancies
2天前
求助中
New perspectives for targeting therapy in ALK-positive human cancers
6个月前
已完结
The signaling pathways activated by ROR1 in cancer
1年前
已完结
Biomarkers of aging for the identification and evaluation of longevity interventions
1年前
已完结
Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer
1年前
已完结
Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer
1年前
已完结
Preclinical safety evaluation of calcineurin inhibitors delivered through an intraductal route to prevent post-ERCP pancreatitis demonstrates endocrine and systemic safety
1年前
已完结
Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer
1年前
已完结
Observation of Local Redox Events at Individual Au Nanoparticles Using Electrogenerated Chemiluminescence Microscopy
1年前
已完结
Conjugation of Biomolecules with Luminophore-Doped Silica Nanoparticles for Photostable Biomarkers
2年前
已完结
皖公网安备34019202002308
